Given how thin the float is I doubt any sane person would be short on this stock. According to the Nasdaq site there is no short interest but given that its an OTC stock they just might not have the data.
It looks like no one wants to relinquish their shares of stock. When that happens, and if the overall feeling of clinical success is positive, doesn't that effect the people who are holding "short positions" ?
The Japanese takeover trend does seem real.
The acquisition of ISCO that makes the most sense to me is by Astellas. They have experience in the process of acquiring and assimilating companies. Given the connection between OCATA and ISCO, this would be an easy combination. MORE important, it would put TWO morally defensible pluripotent stem cells under one roof -- ISCO's parthogenetic and OCATA's blastomere procedures.
I know that Adult Stem Cells is the most acceptable by ULTRA conservatives at this time; however, IMHO, that will change since it is more expensive and less effective due to potency of the cells.
I've wrote about my concerns before about a MERGER takeover. Astellas got OCATA cheap. They could get ISCO evem cheaper with this procedure. If Astellas wants ISCO, it's in the hands of Audrey and Ruslan Semechkin. They nearly own a controlling interest in the company by themselves.
Japanese Companies seem to value American Stem Cell Companies a lot more then the US markets.
Fujifilm bought Cellular Dynamics for $307m.
Astellas bought OCAT for $379m
ISCO's MC is only $12m.
I know ISCO pays OCAT for some licenses. Maybe this is effecting their market cap? Their IP and Patents still look to have more value then the market is crediting them. Especially with the EU ruling.
i was in to-think i got screwd-made afew thousand should have been 60 or 700000-bill==they seem to get us one way or the other--bill
Sentiment: Strong Buy
the 2014 Q4 report wasn't filed until 3/30/15, so I imagine this one wont be filed until at or near 3/30/16. I don't see anything to worry about.
Yes, I took a HUGE loss got out at $3.65 avg even though I did buy some at $2.80. I would have held on but that press release concerned me. It has a headline giving the impression that it raised $6.3 million but in reality only got $2.5 million. This barely enough to get through a month or two. The other $25.7 million is based on warrants being exercised at $3.65 (within 5 years!) and 3.2 million shares at $1.75 within 6 months and another 3.2 million shares at $1.75 within 1 year. Without really looking at the specifics it may not sound all that bad but when you do you realize that the 3.2 million warrants at $3.65 will not be exercised anytime soon but the 6.4 million warrants at $1.75 maybe more likely but only if they think they can sell them. In order for them to exercise and sell them there has to be volume. How does one sell 2x the present float when the avg volume is only around 20k?? You don't or you create demand by coming out with a good story/finding/etc. However this stock has never really responded to anything good the company has put out. I was very torn in selling but based on the above, I had to sell most of my position. I don't want to be one of those bashers, I am not. But if they are most likely going to exercise those $1.75 warrants, I also want to get back in around that price as well. I am very excited about the cartledge/Retinal replacement/phase 1 for Parkinson. I really want ISCO to be sucessful. I hope I am not wrong about where the price is going and that I sold when I shouldn't have but logically it was the only real choice. This is most likely my last post until I get back in. I know us longs have taken a huge hit but I still have faith long term. Peace
Sorry to see you got some negative responses. Somewhat understandable since people do put there hearts and souls into their buys. I suspect if you have been in since 2012 you took a bath on your sell order. I have been in longer and have been hurt bad by the dilution, especially prior to their split when they sold a #$%$ load of stock for 15 cents 2 days after I bought a #$%$ load for 30 cents. But I am still here. I still see good potential for this stock, even with dilution. I would hope this round gets them through to the end of the first phase, but I doubt it will. I think their revenues will continue to grow, not at a very high rate, but still grow to help stave off excessive future dilution. I think the Parkinsons results will be positive. I think if this company gets noticed more by the right groups, the dilutions could be overshadowed by future gains. Your comment that you might get back in under 2 shows you have a constitution that can wait and see if a better buy low period materializes, as it just might. Longer term, if the Parkinsons does show good human results and revenues continue to grow with lifeline type products, today's price at some point will still look like a bargain.
Best of luck to you and especially all longs hanging in there.
Wishing all the best of Good Buys!
We know they need the money but I agree it would have been nice if they could have found a way to at least get the first patient treated and the PPS up prior to the offering.
Perhaps they needed to ensure that the Phase 1 was fully funded before the independent investigators would proceed. But that's just speculation.
Okay. Clearly I'm an idiot. I thought you were claiming you sold 401k shares or 401k dollars worth. I didn't make the correlation because I've never had a 401k. I'm sorry for being rude and stupid. I really thought you were lying. Not sure why Yahoo says I've been a member since yesterday. Thiswelldefend has been my email address for years. I just never posted on any financial message boards till yesterday. Guess I should have kept it that way. I love ISCO and will hold till it makes me a lot of money or till it goes bankrupt. Just can't stomach selling here when any event could spike the price and prevent me from getting back a lot of shares.
Sentiment: Strong Buy
B_B, I totally agree and trust me i did factor in all that. I really wished that this placement was done AFTER the study; where the company would not have had to issue so many low priced warrants and maybe the stock price would have been much greater based on "leaked" progress. The deciding factor for me was that those warrants are probably in weak hands (looking for a quick return vs holding) and the numberof warrants involved considering the daily volume. I could only see major short term selling preasure. But Like I said, the company just did what was best for them. I really like the company's possibilties on many exciting fronts but had to get out (for now) based on what I believe.
I wouldn't count on 8-10 months. The PR of the first treated patient could make headlines and drive the PPS. Also, there is nothing stopping the patients from going to social media. If the results are positive word will get out quickly. Even if the triple the number of shares it's still only an market cap of $30 mil. With good news the market cap will quickly move above $200 mil.